Day Range0.334 - 0.360 | 52 Wk Range0.125 - 2.030 | Open / Close0.334 / - | Float / Outstanding24.647M / 48.845M |
Vol / Avg.355.553K / 1.911M | Mkt Cap17.296M | P/E- | 50d Avg. Price0.190 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float24.647M | EPS-0.490 |
Calyxt Stock (NASDAQ: CLXT) stock price, news, charts, stock research, profile.
Day Range0.334 - 0.360 | 52 Wk Range0.125 - 2.030 | Open / Close0.334 / - | Float / Outstanding24.647M / 48.845M |
Vol / Avg.355.553K / 1.911M | Mkt Cap17.296M | P/E- | 50d Avg. Price0.190 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float24.647M | EPS-0.490 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-02 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.130 | 0.0100 | ||||
REV | 270.000K | 42.000K | -228.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Calyxt (NASDAQ: CLXT) through any online brokerage.
Other companies in Calyxt’s space includes: Cellectar Biosciences (NASDAQ:CLRB), Addex Therapeutics (NASDAQ:ADXN), Humanigen (NASDAQ:HGEN), Trevena (NASDAQ:TRVN) and Indaptus Therapeutics (NASDAQ:INDP).
The latest price target for Calyxt (NASDAQ: CLXT) was reported by HC Wainwright & Co. on Friday, November 4, 2022. The analyst firm set a price target for 0.00 expecting CLXT to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Calyxt (NASDAQ: CLXT) is $0.3541 last updated Today at January 31, 2023 at 6:03 PM UTC.
There are no upcoming dividends for Calyxt.
Calyxt’s Q4 earnings are confirmed for Thursday, March 2, 2023.
There is no upcoming split for Calyxt.
Calyxt is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Calyxt Stock (NASDAQ: CLXT) stock price, news, charts, stock research, profile.
Day Range0.334 - 0.360 | 52 Wk Range0.125 - 2.030 | Open / Close0.334 / - | Float / Outstanding24.647M / 48.845M |
Vol / Avg.355.553K / 1.911M | Mkt Cap17.296M | P/E- | 50d Avg. Price0.190 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float24.647M | EPS-0.490 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-02 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.130 | 0.0100 | ||||
REV | 270.000K | 42.000K | -228.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Calyxt (NASDAQ: CLXT) through any online brokerage.
Other companies in Calyxt’s space includes: Cellectar Biosciences (NASDAQ:CLRB), Addex Therapeutics (NASDAQ:ADXN), Humanigen (NASDAQ:HGEN), Trevena (NASDAQ:TRVN) and Indaptus Therapeutics (NASDAQ:INDP).
The latest price target for Calyxt (NASDAQ: CLXT) was reported by HC Wainwright & Co. on Friday, November 4, 2022. The analyst firm set a price target for 0.00 expecting CLXT to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Calyxt (NASDAQ: CLXT) is $0.3541 last updated Today at January 31, 2023 at 6:03 PM UTC.
There are no upcoming dividends for Calyxt.
Calyxt’s Q4 earnings are confirmed for Thursday, March 2, 2023.
There is no upcoming split for Calyxt.
Calyxt is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Calyxt Stock (NASDAQ: CLXT) stock price, news, charts, stock research, profile.
Day Range0.334 - 0.360 | 52 Wk Range0.125 - 2.030 | Open / Close0.334 / - | Float / Outstanding24.647M / 48.845M |
Vol / Avg.355.553K / 1.911M | Mkt Cap17.296M | P/E- | 50d Avg. Price0.190 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float24.647M | EPS-0.490 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-02 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.130 | 0.0100 | ||||
REV | 270.000K | 42.000K | -228.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Calyxt (NASDAQ: CLXT) through any online brokerage.
Other companies in Calyxt’s space includes: Cellectar Biosciences (NASDAQ:CLRB), Addex Therapeutics (NASDAQ:ADXN), Humanigen (NASDAQ:HGEN), Trevena (NASDAQ:TRVN) and Indaptus Therapeutics (NASDAQ:INDP).
The latest price target for Calyxt (NASDAQ: CLXT) was reported by HC Wainwright & Co. on Friday, November 4, 2022. The analyst firm set a price target for 0.00 expecting CLXT to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Calyxt (NASDAQ: CLXT) is $0.3541 last updated Today at January 31, 2023 at 6:03 PM UTC.
There are no upcoming dividends for Calyxt.
Calyxt’s Q4 earnings are confirmed for Thursday, March 2, 2023.
There is no upcoming split for Calyxt.
Calyxt is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Calyxt Stock (NASDAQ: CLXT) stock price, news, charts, stock research, profile.
Day Range0.334 - 0.360 | 52 Wk Range0.125 - 2.030 | Open / Close0.334 / - | Float / Outstanding24.647M / 48.845M |
Vol / Avg.355.553K / 1.911M | Mkt Cap17.296M | P/E- | 50d Avg. Price0.190 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float24.647M | EPS-0.490 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-02 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.130 | 0.0100 | ||||
REV | 270.000K | 42.000K | -228.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Calyxt (NASDAQ: CLXT) through any online brokerage.
Other companies in Calyxt’s space includes: Cellectar Biosciences (NASDAQ:CLRB), Addex Therapeutics (NASDAQ:ADXN), Humanigen (NASDAQ:HGEN), Trevena (NASDAQ:TRVN) and Indaptus Therapeutics (NASDAQ:INDP).
The latest price target for Calyxt (NASDAQ: CLXT) was reported by HC Wainwright & Co. on Friday, November 4, 2022. The analyst firm set a price target for 0.00 expecting CLXT to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Calyxt (NASDAQ: CLXT) is $0.3541 last updated Today at January 31, 2023 at 6:03 PM UTC.
There are no upcoming dividends for Calyxt.
Calyxt’s Q4 earnings are confirmed for Thursday, March 2, 2023.
There is no upcoming split for Calyxt.
Calyxt is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Calyxt Stock (NASDAQ: CLXT) stock price, news, charts, stock research, profile.
Day Range0.334 - 0.360 | 52 Wk Range0.125 - 2.030 | Open / Close0.334 / - | Float / Outstanding24.647M / 48.845M |
Vol / Avg.355.553K / 1.911M | Mkt Cap17.296M | P/E- | 50d Avg. Price0.190 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float24.647M | EPS-0.490 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-02 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.130 | 0.0100 | ||||
REV | 270.000K | 42.000K | -228.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Calyxt (NASDAQ: CLXT) through any online brokerage.
Other companies in Calyxt’s space includes: Cellectar Biosciences (NASDAQ:CLRB), Addex Therapeutics (NASDAQ:ADXN), Humanigen (NASDAQ:HGEN), Trevena (NASDAQ:TRVN) and Indaptus Therapeutics (NASDAQ:INDP).
The latest price target for Calyxt (NASDAQ: CLXT) was reported by HC Wainwright & Co. on Friday, November 4, 2022. The analyst firm set a price target for 0.00 expecting CLXT to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Calyxt (NASDAQ: CLXT) is $0.3541 last updated Today at January 31, 2023 at 6:03 PM UTC.
There are no upcoming dividends for Calyxt.
Calyxt’s Q4 earnings are confirmed for Thursday, March 2, 2023.
There is no upcoming split for Calyxt.
Calyxt is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Calyxt Stock (NASDAQ: CLXT) stock price, news, charts, stock research, profile.
Day Range0.334 - 0.360 | 52 Wk Range0.125 - 2.030 | Open / Close0.334 / - | Float / Outstanding24.647M / 48.845M |
Vol / Avg.355.553K / 1.911M | Mkt Cap17.296M | P/E- | 50d Avg. Price0.190 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float24.647M | EPS-0.490 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-02 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.130 | 0.0100 | ||||
REV | 270.000K | 42.000K | -228.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Calyxt (NASDAQ: CLXT) through any online brokerage.
Other companies in Calyxt’s space includes: Cellectar Biosciences (NASDAQ:CLRB), Addex Therapeutics (NASDAQ:ADXN), Humanigen (NASDAQ:HGEN), Trevena (NASDAQ:TRVN) and Indaptus Therapeutics (NASDAQ:INDP).
The latest price target for Calyxt (NASDAQ: CLXT) was reported by HC Wainwright & Co. on Friday, November 4, 2022. The analyst firm set a price target for 0.00 expecting CLXT to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Calyxt (NASDAQ: CLXT) is $0.3541 last updated Today at January 31, 2023 at 6:03 PM UTC.
There are no upcoming dividends for Calyxt.
Calyxt’s Q4 earnings are confirmed for Thursday, March 2, 2023.
There is no upcoming split for Calyxt.
Calyxt is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Calyxt Stock (NASDAQ: CLXT) stock price, news, charts, stock research, profile.
Day Range0.334 - 0.360 | 52 Wk Range0.125 - 2.030 | Open / Close0.334 / - | Float / Outstanding24.647M / 48.845M |
Vol / Avg.355.553K / 1.911M | Mkt Cap17.296M | P/E- | 50d Avg. Price0.190 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float24.647M | EPS-0.490 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-02 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.130 | 0.0100 | ||||
REV | 270.000K | 42.000K | -228.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Calyxt (NASDAQ: CLXT) through any online brokerage.
Other companies in Calyxt’s space includes: Cellectar Biosciences (NASDAQ:CLRB), Addex Therapeutics (NASDAQ:ADXN), Humanigen (NASDAQ:HGEN), Trevena (NASDAQ:TRVN) and Indaptus Therapeutics (NASDAQ:INDP).
The latest price target for Calyxt (NASDAQ: CLXT) was reported by HC Wainwright & Co. on Friday, November 4, 2022. The analyst firm set a price target for 0.00 expecting CLXT to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Calyxt (NASDAQ: CLXT) is $0.3541 last updated Today at January 31, 2023 at 6:03 PM UTC.
There are no upcoming dividends for Calyxt.
Calyxt’s Q4 earnings are confirmed for Thursday, March 2, 2023.
There is no upcoming split for Calyxt.
Calyxt is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Calyxt Stock (NASDAQ: CLXT) stock price, news, charts, stock research, profile.
Day Range0.334 - 0.360 | 52 Wk Range0.125 - 2.030 | Open / Close0.334 / - | Float / Outstanding24.647M / 48.845M |
Vol / Avg.355.553K / 1.911M | Mkt Cap17.296M | P/E- | 50d Avg. Price0.190 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float24.647M | EPS-0.490 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-02 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.130 | 0.0100 | ||||
REV | 270.000K | 42.000K | -228.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Calyxt (NASDAQ: CLXT) through any online brokerage.
Other companies in Calyxt’s space includes: Cellectar Biosciences (NASDAQ:CLRB), Addex Therapeutics (NASDAQ:ADXN), Humanigen (NASDAQ:HGEN), Trevena (NASDAQ:TRVN) and Indaptus Therapeutics (NASDAQ:INDP).
The latest price target for Calyxt (NASDAQ: CLXT) was reported by HC Wainwright & Co. on Friday, November 4, 2022. The analyst firm set a price target for 0.00 expecting CLXT to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Calyxt (NASDAQ: CLXT) is $0.3541 last updated Today at January 31, 2023 at 6:03 PM UTC.
There are no upcoming dividends for Calyxt.
Calyxt’s Q4 earnings are confirmed for Thursday, March 2, 2023.
There is no upcoming split for Calyxt.
Calyxt is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Calyxt Stock (NASDAQ: CLXT) stock price, news, charts, stock research, profile.
Day Range0.334 - 0.360 | 52 Wk Range0.125 - 2.030 | Open / Close0.334 / - | Float / Outstanding24.647M / 48.845M |
Vol / Avg.355.553K / 1.911M | Mkt Cap17.296M | P/E- | 50d Avg. Price0.190 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float24.647M | EPS-0.490 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-02 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.130 | 0.0100 | ||||
REV | 270.000K | 42.000K | -228.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Calyxt (NASDAQ: CLXT) through any online brokerage.
Other companies in Calyxt’s space includes: Cellectar Biosciences (NASDAQ:CLRB), Addex Therapeutics (NASDAQ:ADXN), Humanigen (NASDAQ:HGEN), Trevena (NASDAQ:TRVN) and Indaptus Therapeutics (NASDAQ:INDP).
The latest price target for Calyxt (NASDAQ: CLXT) was reported by HC Wainwright & Co. on Friday, November 4, 2022. The analyst firm set a price target for 0.00 expecting CLXT to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Calyxt (NASDAQ: CLXT) is $0.3541 last updated Today at January 31, 2023 at 6:03 PM UTC.
There are no upcoming dividends for Calyxt.
Calyxt’s Q4 earnings are confirmed for Thursday, March 2, 2023.
There is no upcoming split for Calyxt.
Calyxt is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.